The future of pathology: What can we learn from the COVID-19 pandemic?

Bethany J Williams¹, Filippo Fraggetta², Matthew G Hanna³, Richard Huang⁴, Jochen Lennerz², Roberto Salgado⁵, S Joseph Sirintrapun⁶, Liron Pantanowitz², Anil Parwani⁷, Mark Zarella⁸, Darren E Treanor^9
1 Department of Histopathology, Leeds Teaching Hospitals NHS Trust and the University of Leeds, Leeds, UK
² Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
⁴ Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
⁵ Division of Research, Peter Mac Callum Cancer Centre, Melbourne, Australia and Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium
⁶ Memorial Sloan Kettering Cancer Center, New York, NY, USA
⁷ Department of Pathology, Wexner Medical Center, Columbus, Ohio
⁸ Department of Pathology, Johns Hopkins Medicine, Maryland, US
⁹ Department of Histopathology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

Correspondence Address:
Dr. Bethany J Williams
Leeds Teaching Hospitals NHS Trust and the University of Leeds, Leeds, LS9 7TF
UK

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/jpi.jpi_29_20